Conception Nemecek

434 total citations
7 papers, 132 citations indexed

About

Conception Nemecek is a scholar working on Hepatology, Organic Chemistry and Molecular Biology. According to data from OpenAlex, Conception Nemecek has authored 7 papers receiving a total of 132 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Hepatology, 2 papers in Organic Chemistry and 2 papers in Molecular Biology. Recurrent topics in Conception Nemecek's work include Liver physiology and pathology (3 papers), Cancer Mechanisms and Therapy (2 papers) and Cancer, Hypoxia, and Metabolism (2 papers). Conception Nemecek is often cited by papers focused on Liver physiology and pathology (3 papers), Cancer Mechanisms and Therapy (2 papers) and Cancer, Hypoxia, and Metabolism (2 papers). Conception Nemecek collaborates with scholars based in France, United States and Germany. Conception Nemecek's co-authors include Philippe Pitchen, Shuying Zhao, Henri B. Kagan, Odile Samuel, J.P. Guilloteau, S. Maignan, Dominique Lesuisse, Corinne Venot, William A. Metz and Fa‐Xiang Ding and has published in prestigious journals such as Cancer Research, Pure and Applied Chemistry and Molecular Cancer Therapeutics.

In The Last Decade

Conception Nemecek

7 papers receiving 128 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Conception Nemecek France 4 75 41 24 17 13 7 132
Takashi Imada Japan 9 84 1.1× 98 2.4× 6 0.3× 16 0.9× 32 2.5× 9 242
Edward P. Vacek United States 9 155 2.1× 87 2.1× 20 0.8× 19 1.1× 5 0.4× 11 256
Laurent Sanière France 7 258 3.4× 78 1.9× 42 1.8× 26 1.5× 7 0.5× 11 373
Stephen Claridge United Kingdom 8 102 1.4× 145 3.5× 8 0.3× 21 1.2× 4 0.3× 13 226
Takeru Ehara Japan 9 55 0.7× 72 1.8× 8 0.3× 30 1.8× 4 0.3× 18 159
Lara S. Kallander United States 7 99 1.3× 111 2.7× 8 0.3× 16 0.9× 7 0.5× 9 207
Adriana Márquez-Quiñones Mexico 5 30 0.4× 90 2.2× 23 1.0× 71 4.2× 11 0.8× 9 256
Eman A. Ahmed Egypt 10 228 3.0× 37 0.9× 16 0.7× 51 3.0× 23 1.8× 34 385
Lukas Fiebig Germany 9 97 1.3× 48 1.2× 37 1.5× 28 1.6× 1 0.1× 13 220
Shuqun Lin United States 8 95 1.3× 76 1.9× 10 0.4× 25 1.5× 2 0.2× 9 195

Countries citing papers authored by Conception Nemecek

Since Specialization
Citations

This map shows the geographic impact of Conception Nemecek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Conception Nemecek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Conception Nemecek more than expected).

Fields of papers citing papers by Conception Nemecek

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Conception Nemecek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Conception Nemecek. The network helps show where Conception Nemecek may publish in the future.

Co-authorship network of co-authors of Conception Nemecek

This figure shows the co-authorship network connecting the top 25 collaborators of Conception Nemecek. A scholar is included among the top collaborators of Conception Nemecek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Conception Nemecek. Conception Nemecek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Égile, Coumaran, Jean‐Paul Nicolas, Elisa Francesconi, et al.. (2014). The Selective Intravenous Inhibitor of the MET Tyrosine Kinase SAR125844 Inhibits Tumor Growth in MET -Amplified Cancer. Molecular Cancer Therapeutics. 14(2). 384–394. 23 indexed citations
2.
Goulaouic, Hélène, Jean‐Paul Nicolas, Loreley Calvet, et al.. (2012). Abstract 845: In vitro and in vivo pharmacology of SAR125844, a potent and selective intravenous MET kinase inhibitor undergoing Phase I clinical trial. Cancer Research. 72(8_Supplement). 845–845. 1 indexed citations
3.
Schio, Laurent, Conception Nemecek, Antonio Ugolini, et al.. (2012). Abstract 2911: SAR125844: a potent and selective ATP-competitive inhibitor of MET kinase. Cancer Research. 72(8_Supplement). 2911–2911. 1 indexed citations
4.
Lesuisse, Dominique, Jacques Mauger, Conception Nemecek, et al.. (2011). Discovery of the first non-ATP competitive IGF-1R kinase inhibitors: Advantages in comparison with competitive inhibitors. Bioorganic & Medicinal Chemistry Letters. 21(8). 2224–2228. 20 indexed citations
5.
Nemecek, Conception, William A. Metz, Fa‐Xiang Ding, et al.. (2010). Design of Potent IGF1‐R Inhibitors Related to Bis‐azaindoles. Chemical Biology & Drug Design. 76(2). 100–106. 34 indexed citations
6.
Mignani, Serge, et al.. (1992). Versatile Methods for the Synthesis of 2-Amino-6-trifluoromethoxy-(nitro)benzothiazoles. Synthetic Communications. 22(19). 2769–2780. 2 indexed citations
7.
Kagan, Henri B., et al.. (1985). A short route to chiral sulfoxides using titanium-mediated asymmetric oxidation. Pure and Applied Chemistry. 57(12). 1911–1916. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026